[Transplacental passage of the pyrimethamine-sulfadoxine combination in the prenatal treatment of congenital toxoplasmosis].

Dorangeon, P; Fay, R; Marx-Chemla, C; Leroux, B; Harika, G; Dupouy, D; Quereux, C; Choisy, H; Pinon, J M; Wahl, P

[Transplacental passage of the pyrimethamine-sulfadoxine combination in the prenatal treatment of congenital toxoplasmosis]. / Passage transplacentaire de l'association pyriméthamine-sulfadoxine lors du traitement anténatal de la toxoplasmose congénitale.

Dorangeon, P; Fay, R; Marx-Chemla, C; Leroux, B; Harika, G; Dupouy, D; Quereux, C; Choisy, H; Pinon, J M; Wahl, P.

Presse Med ; 19(44): 2036, 1990.

Article in Fr | MEDLINE | ID: mdl-2148622

Subject(s)

Maternal-Fetal Exchange/drug effects; Pyrimethamine/therapeutic use; Sulfadoxine/therapeutic use; Toxoplasmosis, Congenital/drug therapy; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pregnancy; Pyrimethamine/blood; Pyrimethamine/pharmacology; Sulfadoxine/blood; Sulfadoxine/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrimethamine / Sulfadoxine / Toxoplasmosis, Congenital / Maternal-Fetal Exchange Type of study: Risk_factors_studies Limits: Female / Humans / Newborn / Pregnancy Language: Fr Journal: Presse Med Year: 1990 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links